Case Study
Optimizing Platelet Availability and Access to a 100% Pathogen Reduced Inventory
3000 2500 2000 1500 1000 0 # Products 2017 2018 2019 Pre-PR Natively Meets Specifications Volume Reduction Pre-splitting Conventional ~100% Pathogen Reduced Measures implemented over time which resulted in an inventory of ~100% pathogen reduced platelets. Case Study: Optimizing Platelet Availability and Access to a 100% Pathogen Reduced Inventory INTERCEPT ® Blood System for Platelets Pathogen Reduction System Community Blood Bank of Northwest Pennsylvania and Western New York (NWPA/WNY) supplies blood products, including 3,000 apheresis platelet products, to 21 hospitals throughout Northwest Pennsylvania and Western New York. The Challenge In light of eBDS culture obsolescence, NWPA/WNY needed to implement either the BacT/Alert® culture or INTERCEPT® pathogen reduction (PR) to m